Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis.

Schnakenberg Martin AM, Bonfils KA, Davis BJ, Smith EA, Schuder K, Lysaker PH.

Schizophr Res Cogn. 2016 Oct 10;6:15-21. doi: 10.1016/j.scog.2016.09.001. eCollection 2016 Dec.

2.

Altered DLPFC-Hippocampus Connectivity During Working Memory: Independent Replication and Disorder Specificity of a Putative Genetic Risk Phenotype for Schizophrenia.

Schneider M, Walter H, Moessnang C, Schäfer A, Erk S, Mohnke S, Romund L, Garbusow M, Dixson L, Heinz A, Romanczuk-Seiferth N, Meyer-Lindenberg A, Tost H.

Schizophr Bull. 2017 Sep 1;43(5):1114-1122. doi: 10.1093/schbul/sbx001.

PMID:
28207073
3.

Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.

Kelley ME, Wan CR, Broussard B, Crisafio A, Cristofaro S, Johnson S, Reed TA, Amar P, Kaslow NJ, Walker EF, Compton MT.

Schizophr Res. 2016 Mar;171(1-3):62-7. doi: 10.1016/j.schres.2016.01.015. Epub 2016 Jan 17.

4.

The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia.

Volk DW, Lewis DA.

Biol Psychiatry. 2016 Apr 1;79(7):595-603. doi: 10.1016/j.biopsych.2015.06.015. Epub 2015 Jun 19. Review.

5.

Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.

Maccarrone M, Guzmán M, Mackie K, Doherty P, Harkany T.

Nat Rev Neurosci. 2014 Dec;15(12):786-801. doi: 10.1038/nrn3846. Review.

6.

The role of cannabinoid 1 receptor expressing interneurons in behavior.

Brown JA, Horváth S, Garbett KA, Schmidt MJ, Everheart M, Gellért L, Ebert P, Mirnics K.

Neurobiol Dis. 2014 Mar;63:210-21. doi: 10.1016/j.nbd.2013.11.001. Epub 2013 Nov 13.

7.

Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia.

Koola MM, Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner HE, McMahon RP, Gorelick DA.

Psychiatry Res. 2013 Oct 30;209(3):273-8. doi: 10.1016/j.psychres.2013.07.044. Epub 2013 Aug 20.

8.

Cannabis withdrawal in chronic cannabis users with schizophrenia.

Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner H, Schroeder JR, McMahon RP, Gorelick DA.

J Psychiatr Res. 2013 Feb;47(2):240-5. doi: 10.1016/j.jpsychires.2012.10.010. Epub 2012 Nov 10.

9.

Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis.

Galvez-Buccollini JA, Proal AC, Tomaselli V, Trachtenberg M, Coconcea C, Chun J, Manschreck T, Fleming J, Delisi LE.

Schizophr Res. 2012 Aug;139(1-3):157-60. doi: 10.1016/j.schres.2012.06.007. Epub 2012 Jun 21.

10.

Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.

Auther AM, McLaughlin D, Carrión RE, Nagachandran P, Correll CU, Cornblatt BA.

Psychol Med. 2012 Dec;42(12):2485-97. doi: 10.1017/S0033291712000803. Epub 2012 Apr 30.

11.

Evaluation and treatment of children and adolescents with psychotic symptoms.

Algon S, Yi J, Calkins ME, Kohler C, Borgmann-Winter KE.

Curr Psychiatry Rep. 2012 Apr;14(2):101-10. doi: 10.1007/s11920-012-0258-y. Review.

12.

Cannabis and schizophrenia spectrum disorders: a review of clinical studies.

Rodrigo C, Rajapakse S.

Indian J Psychol Med. 2009 Jul;31(2):62-70. doi: 10.4103/0253-7176.63575.

13.

The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.

Leeson VC, Harrison I, Ron MA, Barnes TR, Joyce EM.

Schizophr Bull. 2012 Jun;38(4):873-80. doi: 10.1093/schbul/sbq153. Epub 2011 Mar 9.

14.

The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.

Yücel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, Conus P, Takagi MJ, Fornito A, Wood SJ, McGorry PD, Pantelis C.

Schizophr Bull. 2012 Mar;38(2):316-30. doi: 10.1093/schbul/sbq079. Epub 2010 Jul 25.

15.

Cannabis use disorders in schizophrenia: effects on cognition and symptoms.

DeRosse P, Kaplan A, Burdick KE, Lencz T, Malhotra AK.

Schizophr Res. 2010 Jul;120(1-3):95-100. doi: 10.1016/j.schres.2010.04.007. Epub 2010 May 18.

16.

Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.

Foti DJ, Kotov R, Guey LT, Bromet EJ.

Am J Psychiatry. 2010 Aug;167(8):987-93. doi: 10.1176/appi.ajp.2010.09020189. Epub 2010 May 17.

17.

Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.

Sevy S, Robinson DG, Napolitano B, Patel RC, Gunduz-Bruce H, Miller R, McCormack J, Lorell BS, Kane J.

Schizophr Res. 2010 Jul;120(1-3):101-7. doi: 10.1016/j.schres.2010.03.037. Epub 2010 May 14.

18.

Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use.

González-Pinto A, Alberich S, Barbeito S, Gutierrez M, Vega P, Ibáñez B, Haidar MK, Vieta E, Arango C.

Schizophr Bull. 2011 May;37(3):631-9. doi: 10.1093/schbul/sbp126. Epub 2009 Nov 13.

19.

Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.

Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF.

Am J Psychiatry. 2009 Nov;166(11):1251-7. doi: 10.1176/appi.ajp.2009.09030311. Epub 2009 Oct 1.

20.

Cannabis and psychosis/schizophrenia: human studies.

D'Souza DC, Sewell RA, Ranganathan M.

Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):413-31. doi: 10.1007/s00406-009-0024-2. Epub 2009 Jul 16. Review.

Supplemental Content

Support Center